Related Experiment Video
Updated: May 26, 2026

Translationally-Relevant Tumor Resection Model for Murine Preclinical Models of Oral Squamous Cell Carcinoma
Published on: April 3, 2026
Head and neck cancer therapeutic vaccines: a review
Abigail Huetteman1, Guilherme Rabinowits1,2
1Morsani College of Medicine, University of South Florida, Tampa, FL, United States.
Abstract:
Head and neck squamous cell carcinoma (HNSCC) accounts for nearly one million new cases of cancer and approximately one half million deaths worldwide each year. The complexity of the tumor microenvironment, the lack of actionable target mutations as well as the increasing resistance of HNSCC to innate immunity pose challenges for development of effective treatment. Personalized cancer vaccines are emerging as a promising treatment strategy in HNSCC. Combining immune checkpoint inhibitor therapy with therapeutic cancer vaccines can enhance immune activation through stimulation of both innate and adaptive immune responses. The ability of therapeutic vaccines to illicit a robust immune response remains promising, however achieving consistent and durable clinical outcome remains a key challenge. In this article, we review the current and emerging strategies in therapeutic vaccination, with a particular focus on personalized cancer vaccines in the treatment of HNSCC.
Insights
Personalized cancer vaccines show promise for head and neck squamous cell carcinoma (HNSCC) treatment. Combining these vaccines with immune checkpoint inhibitors may enhance immune responses, though durable outcomes remain a challenge.
Area of Science:
- Oncology
- Immunology
- Cancer Research
Background:
- Head and neck squamous cell carcinoma (HNSCC) presents significant global health challenges, with high incidence and mortality rates.
- Tumor microenvironment complexity, limited actionable mutations, and immune resistance impede effective HNSCC treatment.
- Personalized cancer vaccines are an emerging therapeutic strategy for HNSCC.
Purpose of the Study:
- To review current and emerging strategies in therapeutic vaccination for HNSCC.
- To focus on the role of personalized cancer vaccines in HNSCC treatment.
- To explore the combination of cancer vaccines with immune checkpoint inhibitors.
Main Methods:
- Review of current literature on therapeutic cancer vaccines in HNSCC.
- Analysis of strategies combining vaccines with immune checkpoint inhibitors.
- Discussion of challenges and future directions in personalized cancer vaccine development for HNSCC.
Main Results:
- Therapeutic cancer vaccines can elicit robust immune responses in HNSCC.
- Combination therapy with immune checkpoint inhibitors shows potential for enhanced immune activation.
- Consistent and durable clinical outcomes with current vaccine strategies remain a key challenge.
Conclusions:
- Personalized cancer vaccines represent a promising avenue for HNSCC treatment.
- Combination of vaccines and immune checkpoint inhibitors may improve therapeutic efficacy.
- Further research is needed to overcome challenges and achieve durable clinical responses in HNSCC.
Related Concept Videos
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Tumor Immunotherapy
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Vaccines
Targeted Cancer Therapies
There are several types of targeted therapies against specific...

